FDA Issues Warning Over Avandia Amid Outcry

Law360, New York (May 21, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has issued a safety warning on Avandia, concerned that the popular diabetes drug significantly boosts the risk of heart attack and heart-related deaths.

On Monday, the FDA tossed out a stiff caution regarding the GlaxoSmithKline medication, which is primarily used to treat type 2 diabetes.

“Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia,” the statement said.

The FDA was quick...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.